Target intelligence / Profile preview

Afferent nerve fiber activation

Molecular classification
Other (physiological process), Not classified as receptor, ion channel, enzyme, transporter, etc., Involves multiple types of primary afferent fibers: Aβ fibers (mechanoreceptors), Aδ fibers (nociceptors and thermoreceptors), C fibers (unmyelinated nociceptors)
01

Overview

Afferent nerve fiber activation refers broadly to the initiation of action potentials in sensory neurons that carry information from peripheral tissues toward the central nervous system. These primary afferents include myelinated Aβ and Aδ fibers—which transmit touch/pressure/pain—and unmyelinated C fibers—which are primarily responsible for slow pain transmission and neurogenic inflammation responses. The type of stimulus (mechanical, thermal, chemical) determines which subset(s) are activated. This physiological event underlies all somatosensory signaling including touch perception and nociception—the neural processes encoding noxious stimuli leading to pain sensation. While modulation or inhibition of these processes is therapeutically relevant for analgesia or anesthesia, "afferent nerve fiber activation" itself does not refer to any one molecule but encompasses diverse cellular mechanisms across multiple cell types.

Other names
Activation of sensory nerve fibersSensory afferent fiber stimulationPrimary afferent excitation
02

Mechanism of action

Not applicable for this entry directly; see above for drug actions on components involved in the process.

03

Biological functions

Signal transduction from periphery to central nervous systemPain perception and transmissionNociception and neurogenic inflammation
04

Disease associations

Pain syndromes/chronic painInflammation/neurogenic inflammationNeuropathic pain conditions
05

Safety considerations

Not applicable—this is not a direct druggable target but rather describes normal and pathological physiology involving many different molecules and pathways.
06

Interacting drugs

Capsaicin activates C-fiber vanilloid receptors causing action potentials in these nerves

2 more in the full profile.

07

Biomarkers

None specific to "afferent nerve fiber activation" as an entity; biomarkers would relate to downstream effects such as substance P release or changes in neural activity patterns.

Beyond the preview

Go deeper on Afferent nerve fiber activation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Afferent nerve fiber activation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call